Metatissue

Ilhavo, Portugal Founded: 2018 • Age: 8 yrs
Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding - 3 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About Metatissue

Metatissue is a company based in Ilhavo (Portugal) founded in 2018 by Joao F Mano and Catarina Custodio. Metatissue offers products and services including Hydrogels and hPLMA Unit. Metatissue operates in a competitive market with competitors including Multus, Nu-Tek Biosciences, Kohjin Bio, Sarvoshadhi Bio and metabolIQ, among others.

  • Headquarter Ilhavo, Portugal
  • Founders Joao F Mano, Catarina Custodio
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $79.77 K (USD), Grant

    Jun 01, 2022

  • Investors
    European Union
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Metatissue

Metatissue offers a comprehensive portfolio of products and services, including Hydrogels and hPLMA Unit.

Primary

Human protein-based gels for 3D cell culture and tissue regeneration.

Lyophilized derivative for customizable hydrogels in research applications.

Funding Insights of Metatissue

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $79,770
  • First Round

    (01 Jan 2021)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2022 Amount Grant - Metatissue Valuation

investors
European Union
Sep, 2021 Amount Grant - Metatissue Valuation

investors
European Union
Jan, 2021 Amount Grant - Metatissue Valuation

investors
European Union

Investors in Metatissue

Metatissue has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
European Union
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location

Investments & Acquisitions by Metatissue

Investments

Financial Statements - Metatissue

Metatissue Comparisons

+
Add Comparison
Available on Premium

Competitors of Metatissue

Metatissue operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multus, Nu-Tek Biosciences, Kohjin Bio, Sarvoshadhi Bio and metabolIQ, among others.

Company Name Domain Founded year HQ Location Description
Multus
domain founded_year HQ Location
Provider of lab-grown meat alternatives
Nu-Tek Biosciences
domain founded_year HQ Location
Develops innovative animal-free peptones and cell culture media for pharmaceutical use.
Kohjin Bio
domain founded_year HQ Location
Tissue culture media provided for regenerative medicine and immunotherapy research.
Sarvoshadhi Bio
domain founded_year HQ Location
Customized cell culture media for biotechnology are developed.
metabolIQ
domain founded_year HQ Location
Developer of cell culture medium for pharmaceutical screening and personalized medicine

Latest news on Metatissue

Frequently Asked Questions about Metatissue

Metatissue was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Metatissue is headquartered in Ilhavo, Portugal. It is registered at Ilhavo, Aveiro, Portugal.

Catarina Custodio is the current CEO of Metatissue. They have also founded this company.

Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications. The companys products chemically modified human-derived proteins to prepare hydrogels, sponges and bioinks that mimic the human environment, enabling researchers to develop in vitro models and reduce the need for animal testing.

Metatissue's top competitors include Multus, Onkologic and Cellular Engineering Technologies.

Metatissue offers Hydrogels and hPLMA Unit.

Metatissue has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available